Orders from 1390 SEK Free delivery from 2895 SEK Ready for pickup dead drop: collect in 5 min Free parcel delivery from 2895 SEK

Substances · Tryptamine derivatives

N,N-DMT

C12H16N2 CAS 61-50-7 Analytical reference material — not for human consumption
Preferred name
N,N-DMT
IUPAC name
2-(1H-indol-3-yl)-N,N-dimethylethanamine
Parent CAS number (reference)
61-50-7
Molecular formula
C12H16N2
Molecular weight
188.27 g/mol
InChIKey
DMULVCHRPCFFGV-UHFFFAOYSA-N
PubChem
CID 6089
Source
PubChem
Verified synonyms & catalog abbreviations
Dimethyltryptamine N N-Dimethyltryptamine DMT NNDMT

Verified Neurochemical & Toxicological Intelligence

N,N-DMT

Psychedelic (5-HT2A agonist; sigma-1 ligand) Unsubstituted N,N-dialkyltryptamine
Verified PubChem & CAS Identity C12H16N2 · CAS 61-50-7 · CID 6089
Calibrated Physical Form Pure Crystalline / Analytical Powder (≥98%)
≥98% Analytical Purity Verified 188.27 g/mol
Peer-Reviewed & Agency Citations 2 · verified sources

Receptor Telemetry & Mechanism of Action

5-HT₂ₐ Perceptual & Visual Signaling Partial Agonist
5-HT₁ₐ / 5-HT₂c Serotonergic Modulation Active
D₂ / Adrenergic Dopaminergic / Somatic Tone Low-Moderate

N,N-DMT is a 5-HT2A/2C/1A agonist and a sigma-1 receptor ligand. Vaporized freebase reaches the brain within seconds and produces a brief, highly visual, often geometric and scene-like psychedelic state. MAO-A in gut and liver destroys swallowed DMT before it is active, which is why oral activity requires an MAOI (ayahuasca or pharmahuasca) and a completely different duration.

Biotransformation & Active Metabolites

Not a prodrug. MAO-A oxidative deamination to indoleacetic acid derivatives, plus N-oxidation, clears it. Those metabolites are not a substitute for the parent experience. 5-MeO-DMT is not a metabolite and not a potency-scaled version of this molecule.

Temporal Pharmacokinetics

Very short, intense visual psychedelic: geometry, scenery, and a rapid return. Distinct from the non-visual whiteout of 5-MeO-DMT.

  1. Onset 20–40 seconds
  2. Peak Window 2–8 minutes
  3. Total Window 5–20 minutes
  4. Residual / Half-Life Reorientation 10–60 minutes. With an MAOI the course becomes hours long; that is a different exposure, not a longer version of a casual vaporized dose.

PsychonautWiki vaporized bands: threshold 2 mg, light 10–20 mg, common 20–40 mg, strong 40–60 mg, heavy above 60 mg. Onset is under a minute. A failed first attempt that was swallowed, or a technique that burned the freebase, is not evidence that the milligrams were too low.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
2 mg vaporized
Cognitive & Sensory

A brief color shift or bodily 'ping' without a developed scene.

Somatic & Autonomic

A short pulse increase and possible throat irritation from the vapor.

Light
10–20 mg vaporized
Cognitive & Sensory

Bright visuals with eyes closed, time dilation, and retained contact with the room.

Somatic & Autonomic

Rush of heart rate and blood pressure, dilated pupils, and a vibrating body sensation.

Common Reference
20–40 mg vaporized
Cognitive & Sensory

Full geometric and scenic immersion, entity-like or landscape imagery, and a break from ordinary time while the body is still in the room.

Somatic & Autonomic

A strong cardiovascular rush, temporary inability to speak coherently, and occasional nausea.

Strong
40–60 mg vaporized
Cognitive & Sensory

Breakthrough-level immersion. Memory of the peak is partial. The room disappears for the subjective duration.

Somatic & Autonomic

Immobility or thrashing, blood-pressure spike, and a few minutes in which the person cannot respond.

Heavy / Toxic Zone
60 mg+ vaporized
Cognitive & Sensory

An overwhelming flood that is mostly amnesic. More material does not reliably 'deepen' a breakthrough that already occurred.

Somatic & Autonomic

Prolonged unresponsiveness relative to the usual 5–20 minute course, vomiting, and injury if the person is not physically safe. Seizure risk rises with lithium or tramadol.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

Lithium

Seizures are the specific concern when lithium meets serotonergic psychedelics, including DMT.

Tramadol and DXM

Seizure threshold and serotonin load. Not a 'calming' addition to the offset.

MAOIs together with any other serotonin releaser (MDMA, 5-MeO-DMT, aMT)

An MAOI is what makes swallowed DMT orally active, but stacking a second serotonergic drug on that inhibition is a serotonin-toxicity pattern. 5-MeO-DMT plus an MAOI is separately life-threatening and is not pharmahuasca.

Elevated Hazard — Avoid

Stimulants and cocaine

Add blood-pressure load to an already sharp cardiovascular rush.

Alcohol, opioids, and GHB

Impair the airway and judgment during a state that can include vomiting and immobility.

Caution / Receptor Attenuation

Cannabis

Often intensifies the imagery and anxiety of an already fast experience.

SSRIs

May blunt intensity. They do not make an MAOI or tramadol combination acceptable.

Structural Isomer & Sibling Comparison

Vaporized N,N-DMT (common 20–40 mg, 5–20 minutes, visual) is not vaporized 5-MeO-DMT (common 6–12 mg, 20–40 minutes, non-visual, more vomiting and collapse). 4-AcO-DMT is an oral psilocin prodrug lasting 4–7 hours and is not a 'slow DMT'. Base tryptamine powder that was swallowed without an MAOI and 'did nothing' has not been shown to be weak.

Physicochemical Stability & Storage

Physical Form: White to yellow-white crystals, waxy solid, or crystalline powder. The freebase has a low melting range and can oil if warmed. The hydrochloride is a salt and is not the usual vaporized form. · Freebase dissolves in ethanol, acetone, and naphtha-type solvents and is the form that vaporizes. It is poorly water-soluble. Salts dissolve in water and decompose or burn if heated like freebase.

Darkens with light and air. Store airtight, cool, and dark. Keep the label distinct from 5-MeO-DMT.

Cross-Tolerance & Dependence Profile

Strong short-term tolerance inside a single session, so immediate repeats are weaker. Longer-term tolerance fades faster than with LSD or 4-substituted tryptamines. Not physically dependence-forming. Psychological pull to repeat breakthroughs is separate from pharmacological withdrawal.

Codes on this card

Short meanings for the abbreviations printed with this substance.

Open the full glossary →
5-HT₂ₐ Serotonin receptor 5-HT2A

5-HT is the laboratory name for serotonin. 2A is one subtype of its receptor. Lysergamide, tryptamine, and many 2C-family cards cite this receptor.

Kᵢ Binding tightness in nanomoles

Ki says how tightly a compound sits on a receptor in a binding test. It is written in nanomoles per litre. A Ki of 1 nM means very tight binding in that experiment.

curve Concentration-response curve

The response curve plots concentration along the bottom and the measured laboratory response up the side. It is usually flat, then steep, then flat again near the top. EC50 sits on the steep middle.

T½ Half-life

Half-life is the time it takes a measured concentration to fall by half. After one half-life, half remains. After another, a quarter of the original measurement remains.

CAS CAS registry number

A CAS number is a passport number for one chemical entry in the CAS registry. The free base and a salt of the same parent usually have different CAS numbers.

IUPAC IUPAC Name & Molecular Formula

The molecular formula counts how many atoms of each element sit in one molecule, while the IUPAC name is the systematic map showing exactly how those atoms are connected.

MAOI / IMAO Monoamine Oxidase Inhibitors (MAOIs)

Compounds and medications that block the enzyme responsible for breaking down serotonin, dopamine, and norepinephrine; combining them with monoamine releasers is life-threatening.

5-HT ↑↑ Serotonergic Overload (Serotonin Toxicity)

A potentially fatal medical emergency caused by excessive synaptic serotonin (for example when mixing two serotonin releasers, MAOIs, or tramadol), marked by hyperthermia and neuromuscular rigidity.

Comprehensive Analytical & Toxicological Monograph

N,N-DMT (2-(1H-indol-3-yl)-N,N-dimethylethanamine; CAS 61-50-7, PubChem CID 6089) is supplied as pure powder or crystals (C12H16N2, 188.27 g/mol). It is a 5-HT2A agonist and sigma-1 ligand. PsychonautWiki's vaporized freebase window is threshold 2 mg, light 10–20 mg, common 20–40 mg, strong 40–60 mg, and heavy above 60 mg, with onset in 20–40 seconds and a total course of 5–20 minutes. Swallowed freebase is inactive because MAO-A clears it; oral activity requires an MAOI and then lasts hours, which is a different risk profile, especially if another serotonin drug is added. It is not 5-MeO-DMT: that compound's common vaporized band is 6–12 mg and the subjective state is a whiteout rather than DMT geometry. Do not combine with lithium or tramadol.

Chemical Architecture & Structural Profile

N,N-DMT (2-(1H-indol-3-yl)-N,N-dimethylethanamine) is a reference compound belonging to the Tryptamine derivatives class, characterized by the molecular formula C12H16N2 and a molar mass of 188.27 g/mol. The parent molecule is indexed under CAS registry number 61-50-7 and in the NCBI PubChem database as CID 6089 (Standard InChIKey: DMULVCHRPCFFGV-UHFFFAOYSA-N).

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), N,N-DMT is indexed within the Substituted tryptamines structural group. Toxicological notes (PsychonautWiki): extremely low toxicity. Dependence liability (PsychonautWiki): non-addictive with a low abuse potential. Documented cross-tolerance class: psychedelics. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations

Documented Contraindications & Interactions

High-risk / Dangerous combinations

Unsafe combinations (elevated hazard)

Uncertain combinations (caution advised)